Great Valley Advisor Group, Inc. Takeda Pharmaceutical CO LTD Transaction History

Great Valley Advisor Group, Inc.

  • $3.84 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 14, 2021
SELL
$16.3 - $17.26 $259,985 - $275,297
-15,950 Closed
0 $0
Q2 2021

Jul 27, 2021
BUY
$16.55 - $18.64 $7,546 - $8,499
456 Added 2.94%
15,950 $268,000
Q1 2021

Apr 20, 2021
BUY
$16.71 - $19.9 $45,835 - $54,585
2,743 Added 21.51%
15,494 $283,000
Q4 2020

Jan 29, 2021
BUY
$15.39 - $18.97 $196,237 - $241,886
12,751 New
12,751 $232,000

Others Institutions Holding TAK

# of Institutions
336
Shares Held
73.8M
Call Options Held
1.96M
Put Options Held
165K
View Full List

About TAKEDA PHARMACEUTICAL CO LTD

TAK Quotes by TradingView
  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $42.3B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Great Valley Advisor Group, Inc. Portfolio

Follow Great Valley Advisor Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Valley Advisor Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Great Valley Advisor Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email